prod.bioprocessintl.com Open in urlscan Pro
2606:4700:4400::6812:2b9a  Public Scan

Form analysis
0 forms found in the DOM

Text Content

BioProcess International is part of the Informa Markets Division of Informa PLC
Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT
This site is operated by a business or businesses owned by Informa PLC and all
copyright resides with them. Informa PLC's registered office is 5 Howick Place,
London SW1P 1WG. Registered in England and Wales. Number 8860726.

AboutSubscribeContribute

Subscribe

Subscribe
REGISTERSign in

Upstream Processing

RELATED TOPICS

 * Bioreactors
 * Expression Platforms
 * Biochemicals/Raw Materials

 * Cell Culture Media
 * Microbial Cell Culture
 * Perfusion Cell Culture

See all
Downstream Processing

RELATED TOPICS

 * Filtration
 * Viral Clearance

 * Separation/Purification
 * Chromatography

See all
Manufacturing

RELATED TOPICS

 * Biosimilars
 * Continuous Bioprocessing
 * Facility Design/Engineering
 * Formulation

 * Single Use
 * Fill/Finish
 * Information Technology

See all
Analytical

RELATED TOPICS

 * QA/QC
 * Cell Line Validation
 * PAT
 * Product Characterization

 * Bioanalytical Methods
 * Process Development
 * Assays

RECENT IN ANALYTICAL

See all
thumbnail
Analytical
[QA] Journal-summary-test[QA] Journal-summary-test
Jan 18, 2024
thumbnail
Analytical
[QA] Journal-attach+limit-set[QA] Journal-attach+limit-set
Jan 3, 2024
Business

RELATED TOPICS

 * Careers & Training
 * Economics
 * Pre-Clinical & Clinical Trials
 * Risk Management

 * Intellectual Property
 * Regulatory Affairs
 * Bioregions

See all
Therapeutic Modalities

RELATED TOPICS

 * Cell Therapies
 * Gene Therapies
 * MAb
 * Emerging Therapeutics

 * Personalized Medicine
 * Large Molecule Development
 * Vaccines

RECENT IN THERAPEUTIC MODALITIES

See all
thumbnail
Therapeutic Modalities
[QA] eBook: Strengthening Europe’s Cell and Gene Therapy Sector — Safeguarding
the Medicines of the Future[QA] eBook: Strengthening Europe’s Cell and Gene
Therapy Sector — Safeguarding the Medicines of the Future
byDan Stanton, Millie Nelson
Jan 17, 2024
Bioprocess Insider

RELATED TOPICS

 * Deal-Making
 * Facilities & Capacity
 * Global Markets
 * Regulations

 * Therapeutic Class
 * Upstream & Downstream Processing
 * Webcasts

RECENT IN BIOPROCESS INSIDER

See all
thumbnail
Bioprocess Insider
[QA] Article-summary-test[QA] Article-summary-test
Jan 3, 2024
1 Min Read


Sponsored By



LATEST NEWS


CDMO FRUSTRATION DRIVING AMBITION FOR ADVANCED THERAPY STARTUP GDMC


SANDOZ PICKS UP COHERUS’ LUCENTIS FOR $170M


INSIDER’S OUT? EVOTEC ‘IMMEDIATELY’ REPORTED EX-CEO SHARE TRADING


BLUEROCK TO COMMERCIALIZE OCULAR DISEASE TREATMENT

More
Gallus Strengthens Biologics CMO Business with Acquisition of Laureate
Undefined Category


GALLUS STRENGTHENS BIOLOGICS CMO BUSINESS WITH ACQUISITION OF LAUREATE


GALLUS STRENGTHENS BIOLOGICS CMO BUSINESS WITH ACQUISITION OF LAUREATE

Biomedical Advanced Research and Development Authority (BARDA) Exercises Option
with Pfenex Inc. To Extend Contract and Increase Funding for the
Undefined Category
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option
with Pfenex Inc. To Extend Contract and Increase Funding for the Development of
a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option
with Pfenex Inc. To Extend Contract and Increase Funding for the Development of
a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
FUJIFILM Diosynth Biotechnologies Opens New Manufacturing Facility
Undefined Category
FUJIFILM Diosynth Biotechnologies Opens New Manufacturing Facility
FUJIFILM Diosynth Biotechnologies Opens New Manufacturing Facility
Pfenex Inc. Awarded a Subcontract by Leidos to Develop a Scalable cGMP
Production Process for a Second Key Malaria Antigen
Undefined Category
Pfenex Inc. Awarded a Subcontract by Leidos to Develop a Scalable cGMP
Production Process for a Second Key Malaria Antigen
Pfenex Inc. Awarded a Subcontract by Leidos to Develop a Scalable cGMP
Production Process for a Second Key Malaria Antigen
Global Markets
CDMO frustration driving ambition for advanced therapy startup GDMC
CDMO frustration driving ambition for advanced therapy startup GDMC


LATEST ISSUE

Panel 1 Title

Panel Sub-title

Panel Label

Panel Link Title
Panel 2

Panel Sub-title

Panel Label

Panel Link Title
Panel 3

Panel Sub-title

Panel Label

Panel Link Title
See more

Upstream Processing


View More

Downstream Processing


View More

Manufacturing


View More


Analytical

Analytical
[QA] Journal-summary-test
[QA] Journal-test

Jan 18, 2024

Analytical
[QA] Journal-attach+limit-set
[QA] Journal-attach+limit-set

Jan 3, 2024

View More

Business

Therapeutic Class
Pluri expands cell therapy capabilities into CDMO space
Pluri enters cell therapy CDMO space

Jan 17, 2024

View More

Therapeutic Modalities

Therapeutic Modalities
[QA] eBook: Strengthening Europe’s Cell and Gene Therapy Sector — Safeguarding
the Medicines of the Future
[QA] eBook: Strengthening Europe’s Cell and Gene Therapy Sector — Safeguarding
the Medicines of the Future

Jan 17, 2024

View More


CONTENT SPOTLIGHT


#

#

Read More

White Papers

Market Watch & Perspectives on Vaccines Manufacturing in APAC
Sponsored Content
Market Watch & Perspectives on Vaccines Manufacturing in APAC
Market Watch & Perspectives on Vaccines Manufacturing in APAC
Clinical-Scale Electroporation of T Cells Improves Treatment in Patients with
Refractory Cancer
Sponsored Content
Clinical-Scale Electroporation of T Cells Improves Treatment in Patients with
Refractory Cancer
Clinical-Scale Electroporation of T Cells Improves Treatment in Patients with
Refractory Cancer

Overcome Challenges and Secure Successful Technology Transfers of Complex
Biological Products in Sterile Manufacturing
Sponsored Content
Overcome Challenges and Secure Successful Technology Transfers of Complex
Biological Products in Sterile Manufacturing
Overcome Challenges and Secure Successful Technology Transfers of Complex
Biological Products in Sterile Manufacturing

View More

Posters

Global Markets
CDMO frustration driving ambition for advanced therapy startup GDMC
CDMO frustration driving ambition for advanced therapy startup GDMC
Deal Making
Sandoz picks up Coherus’ Lucentis for $170m
Sandoz picks up Coherus’ Lucentis for $170m

Regulations
Insider’s out? Evotec ‘immediately’ reported ex-CEO share trading
Insider’s out? Evotec ‘immediately’ reported ex-CEO share trading

View More

Videos

Jing Guo, Research Scientist, MIT
Sponsored Content
Jing Guo, Research Scientist, MIT
Jing Guo, Research Scientist, MIT
Not Your Typical CDMO: Comprehensive Cell Solutions
Sponsored Content
Not Your Typical CDMO: Comprehensive Cell Solutions
Not Your Typical CDMO: Comprehensive Cell Solutions

Biovian, a Nordic One-Stop-Shop CDMO
Sponsored Content
Biovian, a Nordic One-Stop-Shop CDMO
Biovian, a Nordic One-Stop-Shop CDMO

View More


Linked Image Demo

View Program

View Program

Latest News


Undefined Category
Lonza adds commercial filling line at Swiss facilityLonza adds commercial
filling line at Swiss facility

Lonza sets up a dedicated cGMP filling line at its Stein site for an undisclosed
customer creating 115 jobs.

Undefined Category
Oxford Biomedica to bolster viral vector capacity with ABL Europe buyOxford
Biomedica to bolster viral vector capacity with ABL Europe buy

Oxford Biomedica is set to add two facilities in France to its CDMO network
through the addition of ABL Europe from Institut Mérieux.

Undefined Category
Sartorius appoints internationally experienced laboratory manager to join its
top management teamSartorius appoints internationally experienced laboratory
manager to join its top management team

Sartorius Goettingen, January 30, 2014 – Effective April 1, 2014, Michael
Melingo will head marketing, sales and services of the Lab Products & Services
Division at Sartorius. He will therefore succeed Dominique Baly, who will retire
from the company as planned after reaching retirement age. Michael Melingo will
report to CEO and Executive Board Chairman Dr. Joachim Kreuzburg and be a member
of the Group Executive Committee, the highest operational management level of
the Sartorius Group. Michael Melingo, who brings more than 30 years of
experience in the industry as a sales and marketing executive, will be joining
Sartorius from Metrohm, the Swiss manufacturer of analytical instruments, where
he was CEO of its U.S. subsidiary. Before that, he had worked for Baxter,
Bio-Rad, Millipore and Waters in Europe and Asia. Michael Melingo is of Austrian
nationality and a bioengineer who specializes in biochemistry and food
technology. “With Michael, we have found an exceptionally experienced manager to
join our t...

View More

Sponsored Videos


Assays
[Test] The body of the article should be displayed correctly instead of the
summary[Test] The body of the article should be displayed correctly instead of
the summary

[Test] The body of the article should be displayed correctly instead of the
summary google.com

Sponsored Content
Accelerate the Manufacturing of Gene and Cell Therapies with GMP Enzymes from
c-LEctaAccelerate the Manufacturing of Gene and Cell Therapies with GMP Enzymes
from c-LEcta

This interview features: Raphael Gübeli, PhD, Head of Marketing , c-LEcta. Dr.
Raphael Gübeli, Head of Marketing at the German enzyme manufacturer c-LEcta will
discuss recent trends related to the manufacturing of cell and gene therapies
and how DENARASE ® and other GMP enzymes can play an important role.

Sponsored Content
Leap-In to the Future of Cell Line DevelopmentLeap-In to the Future of Cell Line
Development

This interview features: Claes Gustafsson, Co-Founder and CCO , ATUM. Launched
only a few years ago, the Leap-In Transposase platform has rapidly become an
industry standard technology for the generation of CHO cells for the
manufacturing of antibodies and other biologics. This presentation will
highlight achievements and case studies of the platform including high titer MAb
manufacturing, rapid anti-COVID responses, and some novel, next generation,
applications. Speaker Bio: As ATUM’s Co-Founder and CCO, Dr. Claes Gustafsson
oversees most of the company’s external communications. Prior to co-founding
ATUM, Dr. Gustafsson led, managed, and collaborated with key strategic teams at
Maxygen Inc. Before Maxygen, Dr. Gustafsson worked as a scientist at Kosan
Biosciences, a number of research, teaching, and post-doctoral positions at UC
Santa Cruz and San Francisco, and at University of Umeå. He received his PhD in
Molecular Biology/Biochemistry from the University of Umeå, Sweden.

View More
[QA] Resources-test
Test Link List

 * [QA] Article-test

 * Biomedical Advanced Research and Development Authority (BARDA) Exercises
   Option with Pfenex Inc. To Extend Contract and Increase Funding for the
   Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine

 * Gallus Strengthens Biologics CMO Business with Acquisition of Laureate

 * FUJIFILM Diosynth Biotechnologies Opens New Manufacturing Facility

See all


BPI CONTENT

BPI ArchiveBioProcess Insider NewsSubscribe to BioProcess Insider Newsletter

RESOURCES

EventsWebinarsWhite PapersPostersVideosPodcasts

ABOUT BPI

Who We AreEditorial AdvisorsAuthor GuidelinesAdvertising/Media KitList
Rental/ReprintsContact UsCareers

JOIN US

Subscribe
Subscribe

FOLLOW US



Copyright © 2024 Informa Connect Limited. Registered in England & Wales with
number 01835199, registered office 5 Howick Place, London, SW1P 1WG.

Cookie Policy|Privacy|Terms|CCPA: Do not sell my personal info

Cookies Button


ABOUT COOKIES ON THIS SITE

We and our partners use cookies to enhance your website experience, learn how
our site is used, offer personalised features, measure the effectiveness of our
services, and tailor content and ads to your interests while you navigate on the
web or interact with us across devices. By clicking "Continue" or continuing to
browse our site you are agreeing to our and our partners use of cookies. For
more information seePrivacy Policy
CONTINUE




COOKIE POLICY

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
More information
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms.    You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work. These cookies do not store any personally identifiable information.

PERFORMANCE COOKIES

Always Active

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site.    All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

FUNCTIONAL COOKIES

Always Active

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages.    If you do not allow these cookies then
some or all of these services may not function properly.

TARGETING COOKIES

Always Active

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites.    They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

Back Button


COOKIE LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Confirm My Choices